RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
-4.7%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$706M
AUM Growth
+$706M
(-27%)
Cap. Flow
-$175M
Cap. Flow
% of AUM
-24.8%
Top 10 Holdings %
Top 10 Hldgs %
84.23%
Holding
36
New
6
Increased
4
Reduced
10
Closed
9
Top Buys
1 |
Ascendis Pharma
ASND
|
$35M |
2 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$20.5M |
3 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$18.7M |
4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$7.57M |
5 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$6.61M |
Top Sells
1 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$70M |
2 |
Nektar Therapeutics
NKTR
|
$63M |
3 |
Aclaris Therapeutics
ACRS
|
$39.6M |
4 |
Ardelyx
ARDX
|
$18.9M |
5 |
TG Therapeutics
TGTX
|
$16.9M |
Sector Composition
1 | Healthcare | 96.66% |